BDBM19346 (R,S)-N-((R)-1-(5-(2-(1H-Indol-3-yl)ethyl)-4-(2,4-dimethoxybenzyl)-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)piperazine-2-carboxamide::N-[(1R)-1-{4-[(2,4-dimethoxyphenyl)methyl]-5-[2-(1H-indol-3-yl)ethyl]-4H-1,2,4-triazol-3-yl}-2-(1H-indol-3-yl)ethyl]piperazine-2-carboxamide::Trisubstituted 1,2,4-Triazole, 54

SMILES COc1ccc(Cn2c(CCc3c[nH]c4ccccc34)nnc2[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C2CNCCN2)c(OC)c1

InChI Key InChIKey=BEAVQQJSWGACGL-XGDNGBMYSA-N

Data  1 IC50  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 19346   

TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Cnrs

LigandPNGBDBM19346((R,S)-N-((R)-1-(5-(2-(1H-Indol-3-yl)ethyl)-4-(2,4-...)
Affinity DataIC50:  32nM Kd:  5nMAssay Description:Specific binding was determined by incubation of membranes from GHS-R1a transfected LLC cells with 125I-His9-ghrelin in the presence of increasing co...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed